Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study | INTERNATIONAL JOURNAL OF CANCER |